Haemonetics (HAE)

NYSE Health Care Health Care Supplies S&P MidCap 400

$119.93

-4.18 (-3.37%)

Close of Nov 06, 2026 · end-of-day data

Source: Haemonetics's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$886.12M	$903.92M	$967.58M	$988.48M	$870.46M	$993.20M	$1.17B	$1.31B	$1.36B	$1.33B
Cost of revenue	$507.62M	$492.01M	$550.04M	$503.97M	$472.62M	$487.69M	$553.56M	$617.51M	$611.87M	$546.44M
Gross profit	$378.49M	$411.91M	$417.54M	$484.51M	$397.84M	$505.50M	$615.10M	$691.55M	$748.96M	$787.59M
Research & development	$37.56M	$39.23M	$35.71M	$30.88M	$32.86M	$46.80M	$50.13M	$54.44M	$62.72M	$59.77M
Selling, general & admin	$301.73M	$316.52M	$273.47M	$282.02M	$275.22M	$340.14M	$376.68M	$429.78M	$436.79M	$442.42M
Operating income	-$19.38M	$56.16M	$83.55M	$103.35M	$89.75M	$80.75M	$156.03M	$164.88M	$221.82M	$156.73M
Interest expense	—	$7.70M	$12.60M	$13.50M	$9.40M	$5.80M	$13.00M	$19.50M	$35.90M	$19.30M
Pre-tax income	-$27.48M	$59.63M	$73.63M	$87.15M	$72.91M	$63.63M	$141.40M	$151.87M	$212.07M	$128.03M
Income tax	-$1.21M	$14.06M	$18.61M	$10.63M	-$6.56M	$20.25M	$26.00M	$34.31M	$44.39M	$30.72M
Net income	-$26.27M	$45.57M	$55.02M	$76.53M	$79.47M	$43.38M	$115.40M	$117.56M	$167.68M	$97.31M
EBITDA	$70.35M	$145.40M	$192.96M	$213.64M	$174.03M	$178.50M	$249.34M	$262.10M	$337.40M	$268.45M
EPS (basic)	$-0.51	$0.86	$1.07	$1.51	$1.57	$0.85	$2.27	$2.32	$3.33	$2.06
EPS (diluted)	$-0.51	$0.85	$1.04	$1.48	$1.55	$0.84	$2.24	$2.29	$3.31	$2.05
Diluted shares	51.52M	53.50M	52.94M	51.81M	51.29M	51.35M	51.42M	51.40M	50.73M	47.35M
Gross margin	42.7%	45.6%	43.2%	49.0%	45.7%	50.9%	52.6%	52.8%	55.0%	59.0%
Operating margin	-2.2%	6.2%	8.6%	10.5%	10.3%	8.1%	13.4%	12.6%	16.3%	11.7%
Net margin	-3.0%	5.0%	5.7%	7.7%	9.1%	4.4%	9.9%	9.0%	12.3%	7.3%

Balance sheet

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & equivalents	$139.56M	$180.17M	$169.35M	$137.31M	$192.31M	$259.50M	$284.47M	$178.80M	$306.76M	$245.44M
Receivables	$152.68M	$151.23M	$185.03M	$165.21M	$127.56M	$159.38M	$179.14M	$206.56M	$202.66M	$216.85M
Inventory	$176.93M	$160.80M	$194.34M	$270.28M	$322.61M	$293.03M	$259.38M	$317.20M	$365.14M	$306.37M
Total current assets	$510.03M	$521.18M	$576.12M	$603.64M	$693.55M	$756.03M	$769.72M	$768.90M	$934.98M	$834.88M
Goodwill	$210.84M	$211.40M	$210.82M	$210.65M	$466.44M	$467.29M	$466.23M	$565.08M	$604.27M	$656.37M
Total assets	$1.24B	$1.24B	$1.27B	$1.27B	$1.82B	$1.86B	$1.93B	$2.20B	$2.45B	$2.40B
Total current liabilities	$211.18M	$384.70M	$235.76M	$274.82M	$253.50M	$442.27M	$251.82M	$300.38M	$578.11M	$282.60M
Short-term debt	$61.02M	$194.26M	$27.67M	$76.98M	$17.02M	$214.15M	$11.78M	$10.23M	$303.56M	$5.01M
Long-term debt	$253.62M	$59.42M	$322.45M	$305.51M	$690.59M	$559.44M	$754.10M	$797.56M	$921.23M	$1.22B
Total debt	$314.65M	$253.68M	$350.12M	$382.49M	$707.61M	$773.59M	$765.89M	$807.79M	$1.22B	$1.22B
Total liabilities	$499.10M	$484.91M	$606.90M	$680.00M	$1.09B	$1.11B	$1.12B	$1.24B	$1.63B	$1.60B
Shareholders' equity	$739.61M	$752.43M	$667.87M	$587.11M	$731.67M	$749.42M	$818.00M	$959.96M	$820.84M	$796.32M

Cash flow

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Operating cash flow	$159.74M	$220.35M	$159.28M	$158.22M	$108.81M	$172.26M	$273.06M	$181.75M	$181.72M	$293.22M
Capital expenditures	$76.14M	$74.80M	$118.96M	$48.76M	$37.04M	$96.51M	$191.33M	$38.12M	$39.28M	$32.78M
Free cash flow	$83.60M	$145.55M	$40.32M	$109.46M	$71.77M	$75.75M	$81.73M	$143.63M	$142.45M	$260.44M
Investing cash flow	-$73.31M	-$63.04M	-$116.15M	-$57.18M	-$425.44M	-$86.34M	-$143.79M	-$322.39M	-$161.90M	-$179.55M
Financing cash flow	-$60.41M	-$120.64M	-$50.63M	-$131.21M	$367.45M	-$15.75M	-$100.36M	$38.16M	$108.82M	-$178.46M
Share buybacks	$0	$100.00M	$160.00M	$175.00M	$0	$0	$75.00M	$0	$225.00M	$175.00M
Stock-based compensation	$9.15M	$13.03M	$17.19M	$20.45M	$25.52M	$24.36M	$25.58M	$28.33M	$29.64M	$33.83M
Depreciation & amortization	$89.73M	$89.25M	$109.42M	$110.29M	$84.29M	$97.75M	$93.31M	$97.22M	$115.59M	$111.72M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$336.25M	$343.29M	$336.17M	$345.51M	$348.54M	$330.60M	$321.39M	$327.31M	$338.97M	$346.35M	$339.38M	$357.76M
Cost of revenue	$158.38M	$167.38M	$161.25M	$158.07M	$155.00M	$137.55M	$129.15M	$132.57M	$136.58M	$148.14M	$136.58M	$136.85M
Gross profit	$177.87M	$175.91M	$174.92M	$187.44M	$193.55M	$193.05M	$192.24M	$194.74M	$202.39M	$198.21M	$202.80M	$220.91M
Research & development	$13.27M	$15.86M	$14.45M	$14.14M	$15.83M	$18.30M	$16.26M	$14.87M	$14.19M	$14.45M	$16.20M	$17.03M
Selling, general & admin	$111.71M	$109.26M	$108.25M	$106.95M	$106.46M	$115.14M	$110.72M	$101.61M	$109.15M	$120.93M	$118.94M	$118.36M
Operating income	$45.98M	$29.94M	$39.76M	$51.70M	$59.03M	$71.33M	$53.87M	$58.49M	$67.40M	-$23.02M	$57.46M	$75.12M
Pre-tax income	$44.03M	$23.41M	$46.71M	$44.70M	$49.92M	$70.74M	$45.17M	$51.28M	$59.98M	-$28.40M	$47.57M	$62.86M
Income tax	$12.79M	$3.05M	$8.34M	$10.87M	$12.42M	$12.76M	$11.14M	$12.60M	$15.23M	-$8.25M	$14.56M	$16.55M
Net income	$31.24M	$20.37M	$38.37M	$33.83M	$37.49M	$57.98M	$34.03M	$38.68M	$44.74M	-$20.15M	$33.01M	$46.30M
EBITDA	$69.51M	$57.58M	$68.89M	$80.91M	$88.05M	$99.54M	$82.63M	$86.75M	$94.78M	$4.29M	$84.57M	$102.88M
EPS (basic)	$0.62	$0.40	$0.75	$0.66	$0.75	$1.17	$0.71	$0.81	$0.96	$-0.41	$0.73	$1.02
EPS (diluted)	$0.61	$0.40	$0.74	$0.66	$0.74	$1.17	$0.70	$0.81	$0.95	$-0.41	$0.72	$1.00
Diluted shares	51.45M	3.00K	51.56M	51.24M	50.64M	-418.00K	48.35M	47.66M	46.99M	-314.00K	45.70M	46.46M
Gross margin	52.9%	51.2%	52.0%	54.2%	55.5%	58.4%	59.8%	59.5%	59.7%	57.2%	59.8%	61.7%
Operating margin	13.7%	8.7%	11.8%	15.0%	16.9%	21.6%	16.8%	17.9%	19.9%	-6.6%	16.9%	21.0%
Net margin	9.3%	5.9%	11.4%	9.8%	10.8%	17.5%	10.6%	11.8%	13.2%	-5.8%	9.7%	12.9%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$193.98M	$178.80M	$344.43M	$299.28M	$320.85M	$306.76M	$292.90M	$296.43M	$363.37M	$245.44M	$223.38M	$260.71M
Receivables	$211.61M	$206.56M	$201.49M	$213.53M	$211.95M	$202.66M	$200.75M	$207.07M	$195.71M	$216.85M	$216.07M	$224.95M
Inventory	$304.02M	$317.20M	$373.79M	$382.11M	$359.61M	$365.14M	$360.53M	$336.21M	$321.19M	$306.37M	$306.74M	$305.01M
Total current assets	$764.98M	$768.90M	$978.58M	$955.90M	$1.01B	$934.98M	$913.16M	$899.68M	$943.67M	$834.88M	$810.83M	$855.53M
Goodwill	$555.00M	$565.08M	$613.35M	$616.16M	$605.27M	$604.27M	$607.30M	$606.10M	$606.83M	$656.37M	$656.88M	$657.10M
Total assets	$2.20B	$2.20B	$2.54B	$2.53B	$2.53B	$2.45B	$2.46B	$2.44B	$2.49B	$2.40B	$2.37B	$2.41B
Total current liabilities	$261.75M	$300.38M	$260.08M	$273.95M	$253.23M	$578.11M	$531.41M	$548.32M	$539.87M	$282.60M	$263.24M	$300.84M
Short-term debt	$13.74M	$10.23M	$5.11M	$5.43M	$5.08M	$303.56M	$303.95M	$304.33M	$304.75M	$5.01M	$4.96M	$9.64M
Long-term debt	$856.85M	$797.56M	$1.22B	$1.22B	$1.22B	$921.23M	$920.83M	$920.39M	$919.99M	$1.22B	$1.17B	$1.11B
Total debt	$870.59M	$807.79M	$1.22B	$1.22B	$1.22B	$1.22B	$1.22B	$1.22B	$1.22B	$1.22B	$1.17B	$1.12B
Total liabilities	$1.26B	$1.24B	$1.64B	$1.65B	$1.62B	$1.63B	$1.58B	$1.59B	$1.58B	$1.60B	$1.53B	$1.51B
Shareholders' equity	$943.32M	$959.96M	$905.37M	$878.85M	$906.86M	$820.84M	$882.30M	$849.17M	$911.45M	$796.32M	$837.10M	$898.50M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	-$540.00K	$64.08M	-$27.42M	$48.82M	$43.77M	$116.56M	$17.39M	$111.32M	$93.56M	$70.94M	$52.32M	$128.10M
Capital expenditures	$14.65M	$6.68M	$5.66M	$9.43M	$8.55M	$15.64M	$3.75M	$5.02M	$6.35M	$17.66M	$7.91M	$14.77M
Free cash flow	-$15.19M	$57.40M	-$33.08M	$39.39M	$35.22M	$100.91M	$13.64M	$106.31M	$87.22M	$53.28M	$44.42M	$113.33M
Investing cash flow	-$268.94M	-$13.06M	-$139.20M	-$23.37M	-$17.37M	$18.04M	-$33.00M	-$30.47M	-$29.47M	-$86.61M	-$22.23M	-$24.29M
Financing cash flow	$109.43M	-$63.50M	$333.69M	-$74.80M	$1.38M	-$151.45M	-$2.44M	-$76.55M	$2.03M	-$101.50M	-$51.53M	-$67.61M
Share buybacks	$0	$0	—	—	$0	$150.00M	—	—	$0	$100.00M	—	—
Stock-based compensation	$7.22M	$7.42M	$7.63M	$6.86M	$8.21M	$6.94M	$9.31M	$7.59M	$7.80M	$9.13M	$9.31M	$10.23M
Depreciation & amortization	$23.53M	$27.64M	$29.14M	$29.22M	$29.02M	$28.21M	$28.76M	$28.25M	$27.39M	$27.32M	$27.11M	$27.76M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.